News
Grove Biopharma Secures $30 Million in Series A to Advance Bionic Biologics™ Platform
Grove Biopharma raises $30 million in Series A funding, led by DCVC Bio and joined by Eli Lilly, to further develop its Bionic Biologics™ platform targeting intracellular disease.
ZymoChem Hits Commercial Production Milestone for BAYSE BioSAP Ingredient
ZymoChem announces the successful commercial-scale production of a key biopolymer for BAYSE™, the world’s first scalable, bio-based, microplastic-free, and biodegradable Super Absorbent Polymer.
Cultivated Biosciences Rebrands as Cosaic, Launches Flagship Ingredient Cosaic Neo
The company has unveiled a new brand identity, Cosaic, alongside the introduction of Cosaic Neo, a next-generation ingredient developed through advanced yeast biotechnology.
Korea Passes Landmark Law to Institutionalize Synthetic Biology Development
South Korea has passed a pioneering law to institutionalize support for synthetic biology. The act includes a national biofoundry, funding plans, and a five-year strategy, aiming to strengthen Korea's position in the fast-growing $3.6 trillion global biotech market.
Verley Launches Precision-Fermented Dairy Protein Portfolio to Advance Functional Food Innovation
French biotech Verley has introduced a novel range of precision-fermented proteins engineered to deliver superior nutrition, taste, and performance over traditional and plant-based dairy ingredients.
Culture Biosciences Launches Stratyx™ 250, First Cloud-Integrated Mobile Bioreactor
Culture Biosciences’ Stratyx™ 250 introduces a cloud-native platform for biotech companies seeking scalable, automated, and remotely managed cell culture systems
NIH-Funded BioClick Project Targets Breakthroughs in Enzyme Engineering
The BioClick initiative, supported by a $300K NIH grant, introduces a novel approach to enzyme engineering aimed at streamlining group transfer reactions critical to synthesizing bio-based compounds and drugs.
IDT and Elegen Partner to Deliver Faster, Cost-Effective Long DNA Synthesis
Integrated DNA Technologies (IDT) has joined forces with Elegen to give early access to ENFINIA™ Plasmid DNA—an advanced clonal gene synthesis service offering NGS-verified long DNA fragments (5–15 kb) within 10 business days. This partnership expands IDT’s synthetic biology solutions for high-throughput, cost-effective workflows.
Industry leaders use Knowledge Hub to explore 510+ Synthetic Biology news
Gain unparalleled insights, and drive your innovation forward.
Let’s shape tomorrow, today!